1)Isaacson PG, Chott A, Nakamura S, et al. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue(MALT lymphoma). In Swerdlow SH, Campo E, Harris NL, et al(eds). World Health Organization Classification of Tumors:WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th ed. IARC, Lyon, pp 214-217, 2008
2)万波智彦,藤原恵子,大藤嘉洋,他.微小な直腸MALTリンパ腫の1例.胃と腸 42:1417-1425, 2007
3)Isaacson PG, Wright DH. Malignant lymphoma of mucosa- associated lymphoid tissue. Cancer 52:1410-1416, 1983
4)Hussell T, Isaacson PG, Crabtree JE, et al. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 342:571-574, 1993
5)渡辺伸和,武内俊,猪野満,他.上行結腸原発低悪性度MALTリンパ腫の1例.日消外会誌 34:1660-1664, 2001
6)味岡洋一,渡辺英伸,丸田和夫,他.大腸にMALT組織,MALTリンパ腫は存在するか? 胃と腸 33:483-484, 1998
7)Shepherd NA, Hall PA, Coates PJ, et al. Primary malignant lymphoma of the colon and rectum. A histopathological and immunohistochemical analysis of 45 cases with clinicopathological correlations. Histopathology 12:235-252, 1988
8)Hirasaki S,Endo H, Nishina T, et al. Mucosa-associated lymphoid tissue lymphoma occurring in the transverse colon. Dig Endosc 15:219-223, 2003
9)Nakamura S, Matsumoto T, Iida M, et al. Primary gastrointestinal lymphoma in Japan:a clinicopathologic analysis of 455 patients with special reference to its time trends. Cancer 97:2462-2473, 2003
10)Ikuta K, Fujiya M, Ueno N, et al. Atypical mucosa-associated lymphoid tissue lymphoma in the transverse colon associated with macroglobulinemia. Intern Med 49:677-682, 2010
11)Matsumoto T, Iida M, Shimizu M, et al. Regression of mucosa- associated lymphoid-tissue lymphoma of rectum after eradication of Helicobacter pylori. Lancet 350:115-116, 1997
12)伊豆津宏二.B細胞リンパ腫に対する最新の薬物/抗体療法.医と薬学 72:607-613, 2015
13)Rummel MJ, Niederle N, Maschmeyer G, et al. Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas:an open-label, multicentre, randomized, phase 3 non-inferiority trial. Lancet 381:1203-1210, 2013